247 related articles for article (PubMed ID: 26939891)
1. B and T Cell Epitope-Based Peptides Predicted from Evolutionarily Conserved and Whole Protein Sequences of Ebola Virus as Vaccine Targets.
Yasmin T; Nabi AH
Scand J Immunol; 2016 May; 83(5):321-37. PubMed ID: 26939891
[TBL] [Abstract][Full Text] [Related]
2. Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules.
Jain S; Baranwal M
J Theor Biol; 2019 Mar; 465():34-44. PubMed ID: 30639295
[TBL] [Abstract][Full Text] [Related]
3. Conserved peptide vaccine candidates containing multiple Ebola nucleoprotein epitopes display interactions with diverse HLA molecules.
Jain S; Baranwal M
Med Microbiol Immunol; 2019 Apr; 208(2):227-238. PubMed ID: 30790057
[TBL] [Abstract][Full Text] [Related]
4. In silico identification of potential epitopes present in human adenovirus proteins for vaccine design and of putative drugs for treatment against viral infection.
Hossain R; Yasmin T; Hosen MI; Nabi AHMN
J Immunol Methods; 2018 Apr; 455():55-70. PubMed ID: 29371093
[TBL] [Abstract][Full Text] [Related]
5. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
6. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS
Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582
[TBL] [Abstract][Full Text] [Related]
7. Epitope-based peptide vaccine design and target site depiction against Ebola viruses: an immunoinformatics study.
Khan MA; Hossain MU; Rakib-Uz-Zaman SM; Morshed MN
Scand J Immunol; 2015 Jul; 82(1):25-34. PubMed ID: 25857850
[TBL] [Abstract][Full Text] [Related]
8. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines.
Dowling W; Thompson E; Badger C; Mellquist JL; Garrison AR; Smith JM; Paragas J; Hogan RJ; Schmaljohn C
J Virol; 2007 Feb; 81(4):1821-37. PubMed ID: 17151111
[TBL] [Abstract][Full Text] [Related]
9. Conserved B and T cell epitopes prediction of ebola virus glycoprotein for vaccine development: An immuno-informatics approach.
Ahmad B; Ashfaq UA; Rahman MU; Masoud MS; Yousaf MZ
Microb Pathog; 2019 Jul; 132():243-253. PubMed ID: 31075428
[TBL] [Abstract][Full Text] [Related]
10. Computational Prediction of Usutu Virus E Protein B Cell and T Cell Epitopes for Potential Vaccine Development.
Palanisamy N; Lennerstrand J
Scand J Immunol; 2017 May; 85(5):350-364. PubMed ID: 28273384
[TBL] [Abstract][Full Text] [Related]
11. Mapping HLA-A2, -A3 and -B7 supertype-restricted T-cell epitopes in the ebolavirus proteome.
Lim WC; Khan AM
BMC Genomics; 2018 Jan; 19(Suppl 1):42. PubMed ID: 29363421
[TBL] [Abstract][Full Text] [Related]
12. Computational design of a potential multi-epitope subunit vaccine using immunoinformatics to fight Ebola virus.
Kadam A; Sasidharan S; Saudagar P
Infect Genet Evol; 2020 Nov; 85():104464. PubMed ID: 32681997
[TBL] [Abstract][Full Text] [Related]
13. Computational elucidation of potential antigenic CTL epitopes in Ebola virus.
Dikhit MR; Kumar S; Vijaymahantesh ; Sahoo BR; Mansuri R; Amit A; Yousuf Ansari M; Sahoo GC; Bimal S; Das P
Infect Genet Evol; 2015 Dec; 36():369-375. PubMed ID: 26462623
[TBL] [Abstract][Full Text] [Related]
14. A common conserved peptide harboring predicted T and B cell epitopes in domain III of envelope protein of Japanese Encephalitis Virus and West Nile Virus for potential use in epitope based vaccines.
Slathia PS; Sharma P
Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():238-245. PubMed ID: 31300121
[TBL] [Abstract][Full Text] [Related]
15. Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus.
Alonso-Padilla J; Lafuente EM; Reche PA
J Immunol Res; 2017; 2017():9363750. PubMed ID: 29119120
[TBL] [Abstract][Full Text] [Related]
16. Epitope distribution in ordered and disordered protein regions. Part B - Ordered regions and disordered binding sites are targets of T- and B-cell immunity.
Pavlović MD; Jandrlić DR; Mitić NS
J Immunol Methods; 2014 May; 407():90-107. PubMed ID: 24726865
[TBL] [Abstract][Full Text] [Related]
17. Exploiting the reverse vaccinology approach to design novel subunit vaccines against Ebola virus.
Ullah MA; Sarkar B; Islam SS
Immunobiology; 2020 May; 225(3):151949. PubMed ID: 32444135
[TBL] [Abstract][Full Text] [Related]
18. In silico T-cell and B-cell Epitope Based Vaccine Design Against Alphavirus Strain of Chikungunya.
Jadoon MH; Rehman Z; Khan A; Rizwan M; Khan S; Mehmood A; Munir A
Infect Disord Drug Targets; 2020; 20(4):523-530. PubMed ID: 31109281
[TBL] [Abstract][Full Text] [Related]
19. Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
Adhikari UK; Rahman MM
Infect Genet Evol; 2017 Dec; 56():75-91. PubMed ID: 29107145
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis.
Sánchez-Burgos G; Ramos-Castañeda J; Cedillo-Rivera R; Dumonteil E
Virus Res; 2010 Oct; 153(1):113-20. PubMed ID: 20638434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]